Use of eribulin and lenvatinib as combination therapy for treatment of cancer
- 专利权人:
- Ltd.;Eisai R&D Management Co.
- 发明人:
- Kenichi Nomoto,Jiayi Wu
- 申请号：
- US14315930
- 公开号：
- US09549922B2
- 申请日:
- 2014.06.26
- 申请国别(地区):
- US
- 年份:
- 2017
- 代理人:
- 摘要：
- The invention provides methods and compositions for use in treating diseases associated with excessive cellular proliferation, such as cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- COMBINATION THERAPY FOR THE TREATMENT OF CANCER COMPRISING ERIBULIN AND LENVATINIB
- Use of eribulin and lenvatinib as combination therapy for treatment of cancer
- USE OF ERIBULIN AND LENVATINIB AS COMBINATION THERAPY FOR TREATMENT OF CANCER
- Use of eribulin and lenvatinib as combination therapy for the treatment of cancer
- גישת אינומותרפיה משולבת לטיפול בסרטן
